BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...

May 21 (Reuters) - Mayne Pharma shares (MYX.AX), opens new tab posted their worst day in 16 years on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a review of its A$672 million ($432.1 ...

Bridgewater-based Cosette issued a statement Dec. 11 saying it served a notice to the Australia-headquartered pharmaceutical company two days prior terminating the agreement. The deal was originally ...

While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of ...

More news: The Supreme Court of NSW dismissed Cosette Pharmaceutical's claims in full on Wednesday, stating that the reluctant suitor waived its right to terminate its acquisition of Mayne Pharma.

More news: Cosette Pharmaceuticals believes there are "material inaccuracies" in Mayne Pharma's response to reports regarding concerns its Salisbury manufacturing facility could be shuttered if ...